HCAT Health Catalyst Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HCAT

Price (delayed)

$1.72

Market cap

$129.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.7

Enterprise value

$238.83M

?
Relative Growth: Rel. Growth: 12
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 35
Relative Profitability: Rel. Profitability: 11
Highlights
Health Catalyst's gross margin has increased by 11% YoY
The company's gross profit rose by 3% YoY but it fell by 2.2% QoQ
The net income has plunged by 165% YoY
HCAT's EPS has dropped by 145% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: http://www.healthcatalyst.com
Peers: PHR PHUN

Key stats

What are the main financial stats of HCAT

HCAT stock price

How has the Health Catalyst stock price performed over time
Intraday
-8.99%
1 week
-0.58%
1 month
12.42%
1 year
-39.65%
YTD
-28.03%
QTD
-13.57%

Financial performance

How have Health Catalyst's revenue and profit performed over time
Revenue
$292.25M
Gross profit
$147.52M
Operating income
-$246.55M
Net income
-$264.82M
Gross margin
50.5%
Net margin
-90.6%
The company's net margin has shrunk by 186% YoY and by 3.3% QoQ
The operating income has dropped by 179% year-on-year
The net income has plunged by 165% YoY
Health Catalyst's gross margin has increased by 11% YoY

Price vs fundamentals

How does HCAT's price correlate with its fundamentals

Growth

What is Health Catalyst's growth rate over time

Valuation

What is Health Catalyst stock price valuation
P/E
N/A
P/B
1.26
P/S
0.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.82
HCAT's EPS has dropped by 145% year-on-year
The company's equity has shrunk by 59% YoY and by 27% QoQ
HCAT's price to book (P/B) is 54% higher than its last 4 quarters average of 0.9 but 18% lower than its 5-year quarterly average of 1.7
The stock's price to sales (P/S) is 80% less than its 5-year quarterly average of 2.4 and 4% less than its last 4 quarters average of 0.5
The company's revenue fell by 8% YoY and by 3.4% QoQ

Efficiency

How efficient is Health Catalyst business performance
HCAT's return on equity is down by 18% since the previous quarter
Health Catalyst's return on assets has decreased by 8% QoQ
The ROIC has grown by 6% from the previous quarter
HCAT's ROS is down by 3.3% since the previous quarter

Dividends

What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCAT.

Financial health

How did Health Catalyst financials performed over time
HCAT's total assets is 39% greater than its total liabilities
The current ratio has soared by 60% from the previous quarter and by 43% YoY
HCAT's total assets is down by 29% year-on-year and by 13% since the previous quarter
The company's debt is 69% higher than its equity
The debt to equity has soared by 141% year-on-year and by 37% since the previous quarter
The company's equity has shrunk by 59% YoY and by 27% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.